Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Specimen Handling × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 67 Prostatic Neoplasms 63 Leukemia, Myeloid, Acute 56 Carcinoma, Non-Small-Cell Lung 54 Neoplasm Metastasis 51 Breast Neoplasms 43 Multiple Myeloma 37 Colorectal Neoplasms 34 Pancreatic Neoplasms 26 Ovarian Neoplasms 26 Carcinoma, Renal Cell 26 Triple Negative Breast Neoplasms 25 Myelodysplastic Syndromes 25 Melanoma 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Large B-Cell, Diffuse 22 Glioblastoma 22 Urinary Bladder Neoplasms 21 Fallopian Tube Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma 16 Endometrial Neoplasms 16 Carcinoma, Hepatocellular 16 Glioma 15 Burkitt Lymphoma 15 Mouth Neoplasms 14 Lymphoma, Follicular 14 Brain Neoplasms 14 Carcinoma 13

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡